| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And COO | SVP, Corp Dev &Strategy
4 companies
Suliman Shehnaaz is a President And COO at ALEC, with reported holdings spanning 4 companies. Recent filings cover 0 purchases and 18 sales. Those positions are worth an estimated $7.8M at current prices.
Our model assigns Suliman Shehnaaz a strong insider score of 78/100, based on 4 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +60.2%.
Suliman Shehnaaz's largest disclosed position is in TBPH as SVP, Corp Dev &Strategy, worth about $2.6M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | TXG 10x Genomics, Inc. | Director | Sell | 5,723 | $81.19 | $464,667.86 | -19.4% | - | - | |
| Aug 24, 2026 | TXG 10x Genomics, Inc. | Director | Sell | 2,207 | $63.65 | $140,477.92 | -7.0% | - | - | |
| Jun 16, 2026 | TXG 10x Genomics, Inc. | Director | Sell | 5,723 | $32.63 | $186,756.11 | -15.3% | - | - | |
| May 18, 2026 | RARE Ultragenyx Pharmaceutical Inc. | Director | Sell | 5,740 | $25.12 | $144,188.80 | -17.0% | - | - | |
| Dec 13, 2021 | ALEC Alector, Inc. | President And COO | Sale+OE | 150,000 | $21.50 | $3,225,315.88 | -59.4% | -37.2% | -57.2% | |
| Dec 9, 2021 | ALEC Alector, Inc. | President And COO | Sale+OE | 150,000 | $22.81 | $3,421,158.89 | -59.4% | -32.8% | -61.5% |